Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2012
07/26/2012US20120192316 Polypeptides having lipase activity and polynucleotides encoding same
07/26/2012US20120192314 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene
07/26/2012US20120192312 Production of Plants with Reduced Lignin Content
07/26/2012US20120192311 Ripening promoter
07/26/2012US20120192310 Novel Bacillus thuringiensis Gene With Lepidopteran Activity
07/26/2012US20120192307 Argyranthemum Intergeneric Hybrid Plants and Methods of Production
07/26/2012US20120192305 Tomato line chi 18-2101
07/26/2012US20120192304 Cotton variety 09r348b2r2
07/26/2012US20120192303 Wild Rocket Cultivar 40-0801188-B
07/26/2012US20120192302 Wheat Variety W000850B1
07/26/2012US20120192299 Inbred c57bl/6 es cells with high developmental capacity
07/26/2012US20120192298 Method for genome editing
07/26/2012US20120192296 Preparation of isolated agonist anti-edar monoclonal antibodies
07/26/2012US20120191179 Base material for forming valved lumen shape tissue, method for producing valved lumen shape tissue, and valved artificial blood vessel
07/26/2012US20120190836 Porphyranases, and use thereof for hydrolyzing polysaccharides
07/26/2012US20120190822 Artificial entropic bristle domain sequences and their use in recombinant protein production
07/26/2012US20120190743 Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity
07/26/2012US20120190731 Methods and compositions to reduce oxidative stress
07/26/2012US20120190730 Targeting cells with altered microrna expression
07/26/2012US20120190718 Diarylthiohydantoin compounds
07/26/2012US20120190668 Enhancement of cellular transplantation using small moleucle modulators of hepatocyte growth factor (scatter factor) activity
07/26/2012US20120190633 Monophosphorylated lipid a derivatives
07/26/2012US20120190630 Amino acid-based compounds, their methods of use, and methods of screening
07/26/2012US20120190629 Light-receiving channel rhodopsin having improved expression efficiency
07/26/2012US20120190623 Inactivation Resistant Factor VIII
07/26/2012US20120190619 Methods of identifying anti-inflammatory compounds
07/26/2012US20120190612 Methods of treatment
07/26/2012US20120190588 Methods for Identifying Agents that Inhibit Cell Migration, Promote Cell Adhesion and Prevent Metastasis
07/26/2012US20120190114 Silicon-incorporated diamond-like carbon film, fabrication method thereof, and its use
07/26/2012US20120190113 Macroporous Microcarrier Specific to Liver Cell, Preparation Method and Use Thereof
07/26/2012US20120190112 Differentiation of Pluripotent Stem Cells
07/26/2012US20120190111 Differentiation of Pluripotent Stem Cells
07/26/2012US20120190110 Immunological uses of immunomodulatory compounds for vaccine and anti-infectious disease therapy
07/26/2012US20120190109 Process for Obtaining Myofibroblasts
07/26/2012US20120190108 Neuronal progenitor cells and methods of derivation and purification of neuronal progenitor cells from embryonic stem cells
07/26/2012US20120190107 Enhanced protein transduction
07/26/2012US20120190098 Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems
07/26/2012US20120190094 Photoreactive Regulator of Protein Function and Methods of Use Thereof
07/26/2012US20120190090 Microbial conversion of plant biomass to advanced biofuels
07/26/2012US20120190086 Ketoreductase-mediated stereoselective route to alpha chloroalcohols
07/26/2012US20120190078 Three-dimensional bioprinting of biosynthetic cellulose (bc) implants and scaffolds for tissue engineering
07/26/2012US20120190070 Sp35 Antibodies and Uses Thereof
07/26/2012US20120190069 Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium
07/26/2012US20120190065 Combinatorial engineering
07/26/2012US20120190059 Methods for obtaining hepatocytes, hepatic endoderm cells and hepatic progenitor cells by induced differentiation
07/26/2012US20120190058 Method for evaluating cell populations
07/26/2012US20120190017 Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (mrp-1) and their use in diagnostic and therapeutic applications
07/26/2012US20120190009 Viral Modulators and Processes Thereof
07/26/2012US20120189663 Method of producing a medical composition
07/26/2012US20120189660 Composition for Preventing or Treating Liver Diseases, Containing Plant Stem Cell Lines Derived from the Cambium of Panax Ginseng Including Mountain Ginseng or Ginseng as Active Ingredient
07/26/2012US20120189656 Reverse genetics using non-endogenous pol i promoters
07/26/2012US20120189655 Attenuated Live Vaccine for Prevention of Porcine Reproductive and Respiratory Syndrome
07/26/2012US20120189648 Infectious hepatitis c viruses of genotype 3a and 4a and uses thereof
07/26/2012US20120189647 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
07/26/2012US20120189643 Toll Like Receptor 3 Antagonists, Methods and Uses
07/26/2012US20120189640 Methods and Compositions Related to Soluble Monoclonal Variable Lymphocyte Receptors of Defined Antigen Specificity
07/26/2012US20120189639 Anti-gitr antibodies
07/26/2012US20120189633 Anti-kit antibodies and uses thereof
07/26/2012US20120189625 Compositions and Methods for Treating Hematological Cancers Targeting the SIRPA CD47 Interaction
07/26/2012US20120189622 Anti-cd38 human antibodies and uses thereof
07/26/2012US20120189618 Superior efficacy of cd37 antibodies in cll blood samples
07/26/2012US20120189617 Anti-tim-3 antibody
07/26/2012US20120189608 New endolysin obpgplys
07/26/2012US20120189606 Antimicrobial Agents
07/26/2012US20120189601 Assisted enzyme replacement therapy
07/26/2012US20120189596 Nuclear receptor and mutant thereof and the use of the same in the reprogramming of cells
07/26/2012US20120189595 Induced pluripotent stem cells and methods of use
07/26/2012US20120189594 Methods for promoting hsc self-renewal
07/26/2012US20120189593 Methods for promoting hsc engraftment
07/26/2012US20120189592 Methods for promoting hematopoietic reconstitution
07/26/2012US20120189587 Cell sheet for tissue repair and bio-artificial tissue engineering, method of producing the same and method of using the same
07/26/2012US20120189578 Compositions and methods for potentiating interleukin-35
07/26/2012US20120189576 3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)
07/26/2012US20120189575 Oligodendrocyte Production from Multipotent Neural Stem Cells
07/26/2012US20120189573 Methods of using death receptor agonists and EGFR inhibitors
07/26/2012US20120189541 Dual Variable Domain Immunnoglobulins and Uses Thereof
07/26/2012DE102010001271B4 Vernähbares Gewebetransplantatkonstrukt zur Rekonstruktion eines menschlichen oder tierischen Organs Seamable tissue graft construct for the reconstruction of a human or animal organ
07/26/2012CA2825388A1 Methods and compositions for modified ethanol inducible promoter systems
07/26/2012CA2825094A1 Pvrl4 (nectin 4) is a receptor for measles virus
07/26/2012CA2824553A1 Somatic cells with innate potential for pluripotency
07/25/2012EP2479277A2 Compositions and methods of use for MGD-CSF in disease treatment
07/25/2012EP2479269A1 Perilla frutescens var. crispa-origin promoter functioning in petal
07/25/2012EP2479262A1 Improved modalities for the treatment of degenerative diseases of the retina
07/25/2012EP2479261A2 Methods for controlling mineralization of extracellular matrix, therapeutic methods based thereon and medicaments for use therein.
07/25/2012EP2479260A1 Microcarriers for stem cell culture
07/25/2012EP2479259A2 Cellular compositions and methods for their preparation
07/25/2012EP2479258A1 Method for isolation of dermal stem cell
07/25/2012EP2479257A1 Use of aminosugars and chondrocytes for the treatment of cartilage and osteochondral defects and lesions
07/25/2012EP2479256A1 Derivation of embryonic stem cells
07/25/2012EP2479189A1 Transferrin fusion protein libraries
07/25/2012EP2478091A1 Stem cell conditioned medium compositions
07/25/2012EP2478013A2 Coiled coil and/or tether containing protein complexes and uses thereof
07/25/2012EP2477658A2 Hiv-1 antibodies
07/25/2012EP2477636A1 Antigen specific tolerogenic antigen presenting cells and related uses compositions, methods and systems
07/25/2012EP1948683B1 Emp4 gene
07/25/2012EP1711531B9 Neutralizing anti tlr4/md-2 antibodies and methods of use thereof
07/25/2012EP1333808B1 Electroprocessed composition used in drug delivery and cell encapsulation
07/25/2012EP1311696B1 Methods for stable transformation of plants
07/25/2012EP1080111B1 The induction of antiobiotic peptides by lait (scd14) protein
07/25/2012CN1653183B Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 1827